Core Pharmaceutical Equipment Fully Complies with EU GMP

24/01/2026

Our company has systematically upgraded and optimized its pharmaceutical equipment and control systems in accordance with the latest requirements of the EU Good Manufacturing Practice (EU GMP). We have further enhanced product standards in aseptic production, data integrity, quality risk management and other key areas, providing global pharmaceutical customers with equipment solutions that better meet international regulatory requirements. As a globally recognized high-standard regulation for the pharmaceutical industry, EU GMP imposes strict requirements on equipment design, production environment, process control, documentation and data management. Adhering to world-class standards, our company strictly follows relevant EU GMP guidelines throughout the entire process of R&D, manufacturing and validation, with a focus on: Aseptic design and cleanroom compatibility to meet high-risk pharmaceutical production environments; Data integrity control (ALCOA+) to ensure production data is attributable, legible, contemporaneous, original, accurate and complete; Standardized validation documentation to support customers in completing DQ/IQ/OQ/PQ validation smoothly; Quality risk management processes to reduce risks from the design stage. After this upgrade, our core equipment meets EU market access requirements in terms of material selection, HMI, automation control, cleaning and sanitization design. It can better serve pharmaceutical companies, CDMOs and international manufacturers in the EU region, helping customers pass GMP audits and on-site inspections successfully. In the future, we will continue to track updates in EU GMP, PIC/S and other international regulations, continuously improve product compliance and technical competitiveness, and provide safe, stable and compliant high-end equipment and services for the global pharmaceutical industry.